false
0001160420
0001160420
2026-08-19
2026-08-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 19, 2026
Commission File Number: 000-33265
| ADIA NUTRITION, INC. |
| (Exact name of registrant as specified in its charter) |
| nevada |
35-2829671 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
4421
Gabriella Ln., Winter Park,
FL, 32792
(Address of principal executive offices)(Zip
Code)
(321)
231-2843
(Registrant’s telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(g) of the Act: Common
A Stock, par value $0.001 per share
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive
Agreement
On August 19, 2026, Adia Nutrition, Inc. (the
“Company”) entered into an engagement letter (the “Engagement Letter”) dated August 14, 2026 with Lucosky Brookman
LLP (the “Firm”) pursuant to which the Firm will act as counsel to the Company with respect to the Company’s planned
uplisting from the OTC Markets to the NASDAQ Capital Market or a similar senior exchange and the Company’s contemplated bridge financing
transaction (the “Bridge Financing”).
The scope of services under the Engagement Letter
for the uplisting and Bridge Financing (the “Uplist and Bridge Financing Services”) includes, but is not limited to:
| (a) | the preparation and/or review and filing of a registration statement on Form S-1 (the “Registration Statement”) with the
Securities and Exchange Commission (the “SEC”);
|
| | | |
| (b) | conducting any necessary due diligence on the Company related to the Registration Statement and the Bridge Financing;
|
| | | |
| (c) | preparation and filing of any responses to SEC comments and filing of any amendments related to the Registration Statement;
|
| | | |
| (d) | preparation and filing of the Company’s application for listing of its securities onto a nationally recognized securities exchange,
including any responses to comments and amendments;
|
| | | |
| (e) | advising on the structure, negotiation, preparation and review of the definitive agreements and related documentation for the Bridge
Financing, including any securities law, corporate governance and regulatory matters arising in connection therewith; and,
|
| | | |
| (f) | assisting the Company with any general corporate matters related to the Registration Statement, the listing application and the Bridge
Financing. Fees for the Uplist and Bridge Financing Services are fixed at $150,000 (the “Uplist and Bridge Financing Services
Fee”); provided, however, that if the total amount of fees incurred for such services, calculated in accordance with the Firm’s
hourly billing rates, exceeds 115% of the Uplist and Bridge Financing Services Fee, the Company shall pay, in addition to the Uplist and
Bridge Financing Services Fee, the amount by which such total hourly fees exceed 115% of the Uplist and Bridge Financing Services Fee. |
The Uplist and Bridge Financing Services Fee is
payable as follows:
| (i) | $30,000 upon the closing of the Bridge Financing;
|
| | | |
| (ii) | $50,000 upon the filing of the Registration Statement with the SEC; and,
|
| | | |
| (iii) | the remaining balance of the Uplist and Bridge Financing Services Fee, together with any additional amounts owing as described above,
upon the closing of the uplisting transaction. |
The Engagement Letter also provides that the Firm
will act as counsel with respect to certain securities work related to the Exchange Act, including (a) periodic Exchange Act filings on
Form 10-K and Form 10-Q; (b) Section 16 filings on Form 3, Form 4 and Form 5 for executive officers of the Company; (c) basic Exchange
Act filings on Form 8-K (not including financings, acquisitions, divestitures or other non-ordinary course transactions); and (d) reviewing
basic press releases on behalf of the Company (the “SEC Services”).
Upon the Company listing its securities onto
Nasdaq or The New York Stock Exchange, the SEC Services shall be billed on a monthly fixed-fee basis in the amount of $8,000 per
month, beginning on the first day of the month after such listing. Fees for additional services not otherwise described in the
Engagement Letter shall be billed on an hourly basis unless a fixed fee has been mutually agreed. The Firm’s hourly rates are:
(a) partners, $600 to $995 per hour; (b) associates and counsel, $450 to $650 per hour; and (c) law clerks and legal assistants,
$300 to $400 per hour (subject to change). The Company is responsible for reimbursement of expenses incurred by the Firm in
connection with the representation. The Engagement Letter contains customary terms and conditions, including provisions
regarding payment of invoices, late fees, engagement of third-party counsel (with Company pre-approval), conflict waivers for
unrelated matters, indemnification and hold-harmless obligations in favor of the Firm, the possible issuance of Company common
shares as payment (with related acknowledgments regarding fairness and potential conflicts), a security interest in the
Company’s assets to secure outstanding obligations, governing law of the State of New York, and exclusive jurisdiction in the
courts of the State of New York. The Engagement Letter is effective retroactively as of the first date the Firm performed legal
services for the Company. Either party may terminate the Engagement Letter upon written notice, subject to payment of outstanding
amounts.
The foregoing description of the Engagement Letter
does not purport to be complete and is qualified in its entirety by reference to the full text of the Engagement Letter, a copy of which
is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and
Exhibits
(d) Exhibits
| Exhibit No. |
|
Description of Exhibit |
| 10.1 |
|
Engagement Letter between Adia Nutrition, Inc. and Lucosky Brookman LLP (dated August 19, 2026) |
| 104 |
|
Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101) |
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
ADIA Nutrition, Inc. |
| |
|
| |
|
| Date: August 24, 2026 |
By: /s/ Larry Powalisz
Name: Larry Powalisz
Title: Chief Executive Officer |
| |
ADIA Nutrition, Inc. |
| |
|
| |
|
| Date: August 24, 2026 |
By: /s/ Rebecca Miller
Name: Rebecca Miller
Title: Chief Financial Officer |
Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.
|
Name |
|
Position |
|
Date |
| |
|
|
|
|
|
/s/ Larry
Powalisz |
|
Chief Executive Officer and Director |
|
August 24, 2026 |
| Larry Powlalisz |
|
|
|
|
| |
|
|
|
|
|
/s/ Rebecca
Miller |
|
Chief Financial Officer |
|
August 24, 2026 |
| Rebecca Miller |
|
|
|
|
| |
|
|
|
|
| /s/ Evan Thomas |
|
Director |
|
August 24, 2026 |
| Evan Thomas |
|
|
|
|
| |
|
|
|
|
| /s/ Kalpesh Barot |
|
Director |
|
August 24, 2026 |
| Kalpesh Barot |
|
|
|
|
| |
|
|
|
|
| /s/ Monica Sher |
|
Director |
|
August 24, 2026 |
| Monica Sher |
|
|
|
|
| |
|
|
|
|
| /s/ Richard Edwards |
|
Director |
|
August 24, 2026 |
| Richard Edwards |
|
|
|
|